Crestline Management, LP Night Hawk Biosciences, Inc. Transaction History
Crestline Management, LP
- $1.28 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding NHWK
# of Institutions
5Shares Held
48.5KCall Options Held
0Put Options Held
0-
Xtx Topco LTD London, X028.8KShares$4,6070.0% of portfolio
-
Goldman Sachs Group Inc New York, NY14.4KShares$2,3030.0% of portfolio
-
Cutler Group LP5KShares$8000.0% of portfolio
-
Huntington National Bank Columbus, OH220Shares$350.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ100Shares$160.0% of portfolio
About NightHawk Biosciences, Inc.
- Ticker NHWK
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,661,500
- Market Cap $4.11M
- Description
- NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...